Latham’s healthcare and life sciences regulatory enforcement and fraud defense team represents US-based clients, including major hospital systems, managed care plans, and pharmaceutical and medical device manufacturers facing healthcare fraud investigations involving the highest level of complexity and controversy. We routinely help clients resolve high-stakes cases involving significant civil, criminal, and administrative exposure.
We bring together deep regulatory knowledge and insight from a team that includes former high-ranking US government lawyers who understand the inner workings of the agencies that regulate the industry. Many of our team members have focused exclusively on healthcare enforcement matters throughout their careers and we draw on this vast collective experience to provide seasoned counsel and representation to the most challenging matters.
Our team of regulatory and reimbursement practitioners, seasoned civil litigators, and experienced criminal trial lawyers brings the optimal defense experience and trial skills to each matter. We resolve most matters discretely and on favorable terms, but always bring a trial-ready mindset backed by an outstanding trial record in the most difficult cases. Our track record of trial and motion practice victories often brings opposing counsel to the table to reach a negotiated resolutions of such matters.
Financial Times recognizes the firm’s strengths across metrics that assess legal industry leadership and strategic growth.
Latham recognized for representing a defendant in an alleged Medicare-related kickback scheme involving a clinical research program testing for opioid addiction risk which concluded with prosecution dropping all charges.
Firm honored for regularly delivering results that dramatically reduce our clients’ financial exposure, prevent or navigate through potentially debilitating litigation, and manage possibly brand-destroying public discourse.